11/23/2023 0 Comments Praxbind fda approvalObtain an accurate medication history.Idarucizumab is a monoclonal antibody specifically targeted at dabigatran, meaning it won’t reverse the effects of other oral anticoagulants.Here are 7 things pharmacists need to know before recommending the use of idarucizumab: ![]() With the approval of idarucizumab, clinicians will have a more efficient tool to use for the reversal of dabigatran.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |